Pharmaceuticals News and Research

RSS

Remaining stocks of Trasylol removed

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that Bayer Pharmaceuticals Corp. agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested an increased risk for death compared to two other drugs used to control bleeding.

15 May 2008

Researchers who helped millions with arthritis receive Janssen Award

Two British researchers who pioneered treatments which have helped millions of people with rheumatoid arthritis and other autoimmune diseases have been awarded the prestigious 2008 Dr. Paul Janssen Award for Biomedical Research, announced today.

13 May 2008

Drug therapy for phenylketonuria reverses heart damage

A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.

13 May 2008

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Rwanda recently accepted a bid from the Toronto-based generic drug company Apotex to supply its fixed-dose combination antiretroviral drug Apo-triAvir to the country, the Toronto Star reports (Toronto Star, 5/9).

13 May 2008

Plants deliver: biofuels, medicines, bioplastics, flavours, pigments...

The need for a renewable and affordable source of carbon that can sustain future economic development without negatively impacting the environment is now widely recognised. It is also apparent that the increasingly high demand for fossil carbon will eventually deplete existing stocks.

12 May 2008

Access to generic HIV/AIDS drugs increasing following Thailand's decision to issue compulsory licenses, health official Says

Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National Health Security Office, said recently, the Bangkok Post reports (Apiradee, Bangkok Post, 5/8).

11 May 2008

Radioactive carbon-14 determines the number of fat cells remains constant in all body types

The radioactive carbon-14 produced by above-ground nuclear testing in the 1950s and '60s has helped researchers determine that the number of fat cells in a human's body, whether lean or obese, is established during the teenage years. Changes in fat mass in adulthood can be attributed mainly to changes in fat cell volume, not an increase in the actual number of fat cells.

9 May 2008

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol), an oral contraceptive product manufactured and marketed by Bayer Schering Pharma, AG.

9 May 2008

FDA approves first generic versions of Requip (ropinirole hydrochloride)

The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.

9 May 2008

Hearing to focus on direct-to-consumer ads for prescription drugs

Officials for Pfizer, Johnson & Johnson, Merck and Schering-Plough on Thursday will testify at a House Energy and Commerce Oversight and Investigations Subcommittee hearing that Democrats hope will "lay the groundwork for future legislation to tighten controls on drug marketing," the Wall Street Journal reports.

8 May 2008

Scientist discovers mechanism that 'silences' unmatched genes during cellular reproduction

When most people discover mold on their bread, they immediately throw it out. Others see a world of possibilities in the tiny fungus. A University of Missouri scientist, along with a collaborative research team, has examined a new mechanism in the reproductive cycle of a certain species of mold.

8 May 2008

New key mechanism in cell division discovered

Scientists at the IFOM-IEO Campus have revealed the function of a protein that is indispensable for passing on an accurate copy of the genome from mother to daughter cells. This study, published in Cell, opens up new avenues of research to reduce the toxicity of chemotherapy in the treatment of cancer.

8 May 2008

Research reveals workings of anti-HIV drugs

Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss Army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus's fierce attack on host cells. The work is described this week (May 7) in the journal Nature.

8 May 2008

Scientists discover how reverse transcriptase molecules interact with the HIV genome

Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus' fierce attack on host cells. The work is described this week in the journal Nature.

7 May 2008

Study suggests caution on a new anti-obesity drug in children

A new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated.

7 May 2008

Apotex receives final tender approval from Rwanda for vital AIDS drug

Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR).

7 May 2008

Antidepressants do work in depression while evidence for cognitive behavioural yherapy is poorer say experts

A new revision of clinical guidelines to help doctors manage patients with depression has challenged the rationale behind the UK government's policy of rolling out of cognitive behavioural therapy (CBT) for milder depression.

7 May 2008

Patent claims allowed covering Samaritan's Alzheimer's memory recovery drug in Australia

Samaritan Pharmaceuticals, a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office.

6 May 2008

Location technologies are improving NHS care

Some of the UK's leading experts in location technologies confirmed this week that applications such as RFID in hospitals are already improving the efficiency and quality of patient care. But they also warn that compatibility problems between hardware and software applications, and a lack of joined up thinking from technology companies mean that the NHS is not benefiting as much as it could.

6 May 2008

Biosimilar protein cooperation

A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals Limited (IBPL).

6 May 2008

Pharmaceuticals News and Research

Remaining stocks of Trasylol removed

Researchers who helped millions with arthritis receive Janssen Award

Drug therapy for phenylketonuria reverses heart damage

Canadian drug company awarded Rwandan contract to provide combination antiretroviral

Plants deliver: biofuels, medicines, bioplastics, flavours, pigments...

Access to generic HIV/AIDS drugs increasing following Thailand's decision to issue compulsory licenses, health official Says

Radioactive carbon-14 determines the number of fat cells remains constant in all body types

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

FDA approves first generic versions of Requip (ropinirole hydrochloride)

Hearing to focus on direct-to-consumer ads for prescription drugs

Scientist discovers mechanism that 'silences' unmatched genes during cellular reproduction

New key mechanism in cell division discovered

Research reveals workings of anti-HIV drugs

Scientists discover how reverse transcriptase molecules interact with the HIV genome

Study suggests caution on a new anti-obesity drug in children

Apotex receives final tender approval from Rwanda for vital AIDS drug

Antidepressants do work in depression while evidence for cognitive behavioural yherapy is poorer say experts

Patent claims allowed covering Samaritan's Alzheimer's memory recovery drug in Australia

Location technologies are improving NHS care

Biosimilar protein cooperation

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring